98 million Indians may have type-2 diabetes by 2030, says a study published in The Lancet Diabetes and Endocrinology journal. The study unveils that the number of adults with the disease worldwide is expected the rise by over a fifth, from 406 million in 2018 to 511 million in 2030, and India along with China and the US will share over half of these high blood sugar cases.
The study shows that China (130 million) followed by India (98 million), and the US (32 million) will constitute over half of type-2 diabetics by 2030. It means 98 million Indians will suffer from type-2 diabetes.
The study predicts that African, Asian, and Oceania regions will not get the proper amount of insulin in 2030 if the access remains at current levels.
The figures in India are already very high, with 1 of 20 people having diabetes and 1 of 15 people on verge of having it. The study is a warning for the treatment of people suffering from type-2 diabetes in the coming years.
The report also says that global insulin use is projected to rise from 526 million 1000-unit vials in 2018 to 634 million in 2030, and will be highest in Asia (322 million vials in 2030) and lowest in Oceania (4 million).
The expected increase in the demand of insulin in the coming 12 years, and the incidence of type-2 diabetes, signalled grave shortage of insulin to treat the patients.
The study said 79 million people with type- 2 diabetes will need insulin by 2030, while insulin required to treat the patients is expected to increase by around 20%. Almost 50% of 79 million people will not get insulin if no significant improvements are made in drug production.
The Guardian quoted Dr. Sanjay Basu from Stanford University in the US, who led the research, as saying the current levels of insulin access are inadequate especially in Africa and Asia, requiring more efforts to overcome this shortage.
Basu further added, “Despite the UN’s commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily difficult for patients to access,” said lead author Sanjay Basu from Stanford University, US. “The number of adults with type-2 diabetes is expected to rise over the next 12 years due to aging, urbanization, and associated changes in diet and physical activity. Unless governments begin initiatives to make insulin available and affordable, then its use is always going to be far from optimal”.